Annual Drug Patent Expirations for VICTOZA
Victoza is a drug marketed by Novo Nordisk Inc and is included in one NDA. It is available from two suppliers. There are eight patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for VICTOZA.
The generic ingredient in VICTOZA is liraglutide recombinant. Two suppliers are listed for this compound. Additional details are available on the liraglutide recombinant profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
